Echolight obtains FDA Clereance.

It’s a great pleasure to announce that Echolight has received the 510(K) approval from the FDA –  U.S. Food and Drug Administration, the governing body that regulates the trade of medical devices within the US market, for its EchoS system and the final authorization to start marketing and selling it since last November.

This new important achievement and recognition obtained internationally, is a fundamental element for the diffusion of the innovative R.E.M.S. technology (Radiofrequency Echographic Multi Spectrometry) worldwide, which thanks to its high levels of precision recognized by the scientific community, in combination with the complete absence of ionizing radiation and proven ease of use, will allow EchoS to be effectively used for the early diagnosis of the osteoporosis and bone health assessment in primary care.

EchoS, entirely developed in Italy, and already marketed in over 30 countries, provides the medical community with the next generation of bone densitometry, capable of evaluating the bone status to prevent fractures and constantly monitor the parameters for disease analysis, aimed at raising the quality of life worldwide.

Echolight in India

Echolight in India

Echolight in India We are pleased to announce that Echolight officially lands in India thanks to the signing of a commercial agreement with an important local partner in Chandigarh, in the north of India for the distribution of the entire range of products throughout...

leggi tutto
Echolight in Australia

Echolight in Australia

R.E.M.S. technology reaches the oceanic continent. We are proud to announce the achievement of sales authorization for the Echolight products issued by the Australia Government Department of Health. So Australia is also opening its doors to R.E.M.S. (Radiofrequency...

leggi tutto
Echolight joins NOF

Echolight joins NOF

Echolight joins National Osteoporosis Foundation's Corporate Advisory Roundtable Innovator in bone density diagnostic technology brings expertise to foundation. SEATTLE, Feb. 23, 2021 /PRNewswire/ -- Echolight Medical, manufacturer of the radiation-free EchoS portable...

leggi tutto
Share This